SEPN - Septerna, Inc.
Price:
--
--
|
CONSENSUS:
Buy
DETAILS
|
PRICE TARGET:
$41.75
DETAILS
HIGH:
$60.00
LOW:
$34.00
MEDIAN:
$36.50
CONSENSUS:
$41.75
UPSIDE:
47.21%
Institutional Holders (13F)
| GURU | SHARES | VALUE | WEIGHT % | SHARES CHG | ACTION |
|---|---|---|---|---|---|
| Soros | 10,000 | $229,000 | 0.0% | +10,000 | NEW |
Insider Trading
| DATE | INSIDER | TITLE | TYPE | SHARES | PRICE | VALUE |
|---|---|---|---|---|---|---|
| 2026-04-15 | Bhatt Elizabeth | officer: President and COO | SELL | 1,101 | $25.24 | $28K |
| 2026-04-15 | Bhatt Elizabeth | officer: President and COO | SELL | 2,573 | $23.76 | $61K |
| 2026-04-15 | Bhatt Elizabeth | officer: President and COO | M-Exempt | 4,000 | $6.81 | $27K |
| 2026-04-15 | Bhatt Elizabeth | officer: President and COO | SELL | 326 | $25.86 | $8K |
| 2026-03-02 | Shaikhly Samira | officer: Chief People Officer | SELL | 66,363 | $28.14 | $1.9M |
| 2026-03-02 | Shaikhly Samira | officer: Chief People Officer | M-Exempt | 5,101 | $2.76 | $14K |
| 2026-03-02 | Shaikhly Samira | officer: Chief People Officer | SELL | 4,090 | $27.51 | $112K |
| 2026-03-02 | Shaikhly Samira | officer: Chief People Officer | M-Exempt | 53,714 | $1.55 | $83K |
| 2026-03-02 | Shaikhly Samira | officer: Chief People Officer | M-Exempt | 11,638 | $2.76 | $32K |
| 2026-02-18 | Bhatt Elizabeth | officer: President and COO | M-Exempt | 4,000 | $6.81 | $27K |
| 2026-02-18 | Bhatt Elizabeth | officer: President and COO | SELL | 1,800 | $29.58 | $53K |
| 2026-02-18 | Bhatt Elizabeth | officer: President and COO | SELL | 2,200 | $28.46 | $63K |
| 2026-02-06 | Kim Jae B. | officer: Chief Medical Officer | A-Award | 125,000 | $25.41 | $3.2M |
| 2026-02-06 | Finer Jeffrey | director, officer: Chief Executive Officer | A-Award | 400,000 | $25.41 | $10.2M |
| 2026-02-06 | Wilson Mark Andrew | officer: Chief Legal Officer | A-Award | 165,000 | $25.41 | $4.2M |
| 2026-02-06 | Bhatt Elizabeth | officer: President and COO | A-Award | 155,000 | $25.41 | $3.9M |
| 2026-02-06 | Long Daniel D. | officer: SVP, Drug Discovery | A-Award | 80,000 | $25.41 | $2.0M |
| 2026-02-06 | Labrucherie Gil M | officer: Chief Financial Officer | A-Award | 125,000 | $25.41 | $3.2M |
| 2026-02-06 | Shaikhly Samira | officer: Chief People Officer | A-Award | 80,000 | $25.41 | $2.0M |
| 2026-02-06 | Klein Uwe | officer: SVP, Biological Sciences | A-Award | 80,000 | $25.41 | $2.0M |
| 2026-01-05 | Wilson Mark Andrew | ? | -- | -- | -- | |
| 2025-11-10 | Long Daniel D. | officer: SVP, Drug Discovery | SELL | 3,501 | $18.06 | $63K |
| 2025-09-25 | Gottesdiener Keith Michael | director | A-Award | 33,246 | $16.75 | $557K |
| 2025-09-25 | Gottesdiener Keith Michael | ? | -- | -- | -- | |
| 2025-08-18 | Klein Uwe | officer: SVP, Biological Sciences | M-Exempt | 10,452 | $2.76 | $29K |